Loading...
Market
What will be the primary use of medical isotopes produced by the Dutch nuclear reactor by December 31, 2026?
2
Resolution / Starting Odds
Cancer Treatment • 25%
Research • 25%
Diagnostic Imaging • 25%
Other • 25%
Reports from Dutch medical institutions or governmental announcements
Story
EU Approves €2 Billion ($2.2 billion) Dutch State Aid for Nuclear Reactor for Cancer Treatment on July 26, 2024
Jul 25, 2024, 10:15 PM
The Dutch government has received approval from the European Union for €2 billion ($2.2 billion) in state aid to construct a nuclear reactor aimed at producing medical isotopes for cancer treatment. This decision, confirmed on July 26, 2024, is contingent upon the stipulation that the isotopes produced will not be sold below cost. The approval is part of broader efforts to enhance the production of medical isotopes, which are critical in cancer therapies. The Dutch authorities have committed to ensuring that the pricing of these products will cover all associated costs, aligning with EU competition regulations.
View original story
Similar markets
Safety regulations • 25%
Increased funding for research • 25%
Promotion of nuclear energy • 25%
Phasing out nuclear energy • 25%
China Advanced Research Reactor • 25%
Huanliu-3 • 25%
Beishan Underground Research Laboratory • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
Space missions • 25%
Deep-sea explorations • 25%
Military applications • 25%
Commercial products • 25%
Technical support • 25%
Financial support • 25%
Regulatory oversight • 25%
Other • 25%
Less than $12 million • 25%
$12 million to $20 million • 25%
$20 million to $30 million • 25%
More than $30 million • 25%
Treatment of A. baumannii infections • 25%
Treatment of other bacterial infections • 25%
Pandemic preparedness • 25%
Other • 25%
United States • 25%
Russia • 25%
France • 25%
Other • 25%
United States • 25%
China • 25%
Russia • 25%
Other • 25%